Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
OMCL's Cash to Debt is ranked higher than
94% of the 1726 Companies
in the Global Health Information Services industry.

( Industry Median: 9.60 vs. OMCL: No Debt )
OMCL' s 10-Year Cash to Debt Range
Min: 0.42   Max: No Debt
Current: No Debt

Equity to Asset 0.70
OMCL's Equity to Asset is ranked higher than
76% of the 1684 Companies
in the Global Health Information Services industry.

( Industry Median: 0.59 vs. OMCL: 0.70 )
OMCL' s 10-Year Equity to Asset Range
Min: -0.57   Max: 0.78
Current: 0.7

-0.57
0.78
Interest Coverage No Debt
OMCL's Interest Coverage is ranked higher than
97% of the 1122 Companies
in the Global Health Information Services industry.

( Industry Median: 718.47 vs. OMCL: No Debt )
OMCL' s 10-Year Interest Coverage Range
Min: 44.6   Max: 2381.5
Current: No Debt

44.6
2381.5
F-Score: 7
Z-Score: 5.04
M-Score: -2.56
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 10.89
OMCL's Operating margin (%) is ranked higher than
82% of the 1723 Companies
in the Global Health Information Services industry.

( Industry Median: 5.62 vs. OMCL: 10.89 )
OMCL' s 10-Year Operating margin (%) Range
Min: -29   Max: 9.27
Current: 10.89

-29
9.27
Net-margin (%) 7.02
OMCL's Net-margin (%) is ranked higher than
78% of the 1723 Companies
in the Global Health Information Services industry.

( Industry Median: 3.80 vs. OMCL: 7.02 )
OMCL' s 10-Year Net-margin (%) Range
Min: -30.86   Max: 20.32
Current: 7.02

-30.86
20.32
ROE (%) 7.56
OMCL's ROE (%) is ranked higher than
71% of the 1682 Companies
in the Global Health Information Services industry.

( Industry Median: 6.25 vs. OMCL: 7.56 )
OMCL' s 10-Year ROE (%) Range
Min: -30.9   Max: 21.02
Current: 7.56

-30.9
21.02
ROA (%) 5.32
OMCL's ROA (%) is ranked higher than
76% of the 1734 Companies
in the Global Health Information Services industry.

( Industry Median: 3.59 vs. OMCL: 5.32 )
OMCL' s 10-Year ROA (%) Range
Min: -47.35   Max: 13.18
Current: 5.32

-47.35
13.18
ROC (Joel Greenblatt) (%) 53.05
OMCL's ROC (Joel Greenblatt) (%) is ranked higher than
78% of the 1722 Companies
in the Global Health Information Services industry.

( Industry Median: 26.91 vs. OMCL: 53.05 )
OMCL' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -397.58   Max: 144.51
Current: 53.05

-397.58
144.51
Revenue Growth (%) 17.00
OMCL's Revenue Growth (%) is ranked higher than
88% of the 1445 Companies
in the Global Health Information Services industry.

( Industry Median: 6.10 vs. OMCL: 17.00 )
OMCL' s 10-Year Revenue Growth (%) Range
Min: -53.3   Max: 17.5
Current: 17

-53.3
17.5
EBITDA Growth (%) 39.70
OMCL's EBITDA Growth (%) is ranked higher than
93% of the 1179 Companies
in the Global Health Information Services industry.

( Industry Median: 7.20 vs. OMCL: 39.70 )
OMCL' s 10-Year EBITDA Growth (%) Range
Min: -14.1   Max: 124.1
Current: 39.7

-14.1
124.1
EPS Growth (%) 64.70
OMCL's EPS Growth (%) is ranked higher than
95% of the 1097 Companies
in the Global Health Information Services industry.

( Industry Median: 7.70 vs. OMCL: 64.70 )
OMCL' s 10-Year EPS Growth (%) Range
Min: -69.7   Max: 260.9
Current: 64.7

-69.7
260.9
» OMCL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

OMCL Guru Trades in Q3 2013

Steven Cohen 14,443 sh (New)
Jim Simons Sold Out
» More
Q4 2013

OMCL Guru Trades in Q4 2013

Paul Tudor Jones 19,574 sh (New)
Joel Greenblatt 72,226 sh (New)
Steven Cohen Sold Out
» More
Q1 2014

OMCL Guru Trades in Q1 2014

Paul Tudor Jones 14,400 sh (-26.43%)
Joel Greenblatt 45,947 sh (-36.38%)
» More
Q2 2014

OMCL Guru Trades in Q2 2014

Ken Fisher 410,000 sh (New)
Jim Simons 103,943 sh (New)
Paul Tudor Jones 16,552 sh (+14.94%)
Joel Greenblatt 43,389 sh (-5.57%)
» More
» Details

Insider Trades

Latest Guru Trades with OMCL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-03-31 Reduce -36.38%0.02%$25.02 - $30.27 $ 27.410%45947
Joel Greenblatt 2013-12-31 New Buy0.04%$22.41 - $25.59 $ 27.4115%72226
Joel Greenblatt 2012-09-30 Sold Out 0.1%$12.79 - $14.97 $ 27.4193%0
Joel Greenblatt 2012-06-30 Add 98.26%0.05%$12.87 - $15.36 $ 27.4193%92061
Joel Greenblatt 2012-03-31 New Buy0.06%$14.22 - $17.85 $ 27.4185%46435
George Soros 2011-12-31 Sold Out 0.0037%$13.05 - $17.05 $ 27.4177%0
George Soros 2011-09-30 Add 25%$13.2 - $17.11 $ 27.4177%15500
George Soros 2011-06-30 New Buy$13.28 - $15.61 $ 27.4184%12400
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 35.20
OMCL's P/E(ttm) is ranked higher than
59% of the 1205 Companies
in the Global Health Information Services industry.

( Industry Median: 22.90 vs. OMCL: 35.20 )
OMCL' s 10-Year P/E(ttm) Range
Min: 8.94   Max: 795.88
Current: 35.2

8.94
795.88
P/B 2.60
OMCL's P/B is ranked higher than
65% of the 1592 Companies
in the Global Health Information Services industry.

( Industry Median: 2.50 vs. OMCL: 2.60 )
OMCL' s 10-Year P/B Range
Min: 0.96   Max: 13.68
Current: 2.6

0.96
13.68
P/S 2.50
OMCL's P/S is ranked higher than
63% of the 1684 Companies
in the Global Health Information Services industry.

( Industry Median: 1.98 vs. OMCL: 2.50 )
OMCL' s 10-Year P/S Range
Min: 0.94   Max: 5.54
Current: 2.5

0.94
5.54
PFCF 28.60
OMCL's PFCF is ranked higher than
62% of the 917 Companies
in the Global Health Information Services industry.

( Industry Median: 20.73 vs. OMCL: 28.60 )
OMCL' s 10-Year PFCF Range
Min: 8   Max: 342.2
Current: 28.6

8
342.2
EV-to-EBIT 19.93
OMCL's EV-to-EBIT is ranked higher than
64% of the 1216 Companies
in the Global Health Information Services industry.

( Industry Median: 16.28 vs. OMCL: 19.93 )
OMCL' s 10-Year EV-to-EBIT Range
Min: 6.3   Max: 424.9
Current: 19.93

6.3
424.9
PEG 0.75
OMCL's PEG is ranked higher than
86% of the 638 Companies
in the Global Health Information Services industry.

( Industry Median: 1.67 vs. OMCL: 0.75 )
OMCL' s 10-Year PEG Range
Min: 0.5   Max: 42.93
Current: 0.75

0.5
42.93
Shiller P/E 72.40
OMCL's Shiller P/E is ranked higher than
54% of the 820 Companies
in the Global Health Information Services industry.

( Industry Median: 26.55 vs. OMCL: 72.40 )
OMCL' s 10-Year Shiller P/E Range
Min: 15.61   Max: 341.86
Current: 72.4

15.61
341.86
Current Ratio 2.67
OMCL's Current Ratio is ranked higher than
73% of the 1308 Companies
in the Global Health Information Services industry.

( Industry Median: 2.02 vs. OMCL: 2.67 )
OMCL' s 10-Year Current Ratio Range
Min: 0.64   Max: 5.21
Current: 2.67

0.64
5.21
Quick Ratio 2.37
OMCL's Quick Ratio is ranked higher than
72% of the 1308 Companies
in the Global Health Information Services industry.

( Industry Median: 1.90 vs. OMCL: 2.37 )
OMCL' s 10-Year Quick Ratio Range
Min: 0.4   Max: 4.95
Current: 2.37

0.4
4.95

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 22.70
OMCL's Price/Net Current Asset Value is ranked lower than
52% of the 628 Companies
in the Global Health Information Services industry.

( Industry Median: 10.94 vs. OMCL: 22.70 )
OMCL' s 10-Year Price/Net Current Asset Value Range
Min: 2.48   Max: 324
Current: 22.7

2.48
324
Price/Tangible Book 5.40
OMCL's Price/Tangible Book is ranked higher than
58% of the 1326 Companies
in the Global Health Information Services industry.

( Industry Median: 4.29 vs. OMCL: 5.40 )
OMCL' s 10-Year Price/Tangible Book Range
Min: 1.2   Max: 16.59
Current: 5.4

1.2
16.59
Price/DCF (Projected) 1.90
OMCL's Price/DCF (Projected) is ranked higher than
67% of the 989 Companies
in the Global Health Information Services industry.

( Industry Median: 1.45 vs. OMCL: 1.90 )
OMCL' s 10-Year Price/DCF (Projected) Range
Min: 0.94   Max: 50.25
Current: 1.9

0.94
50.25
Price/Median PS Value 1.10
OMCL's Price/Median PS Value is ranked higher than
71% of the 1607 Companies
in the Global Health Information Services industry.

( Industry Median: 1.11 vs. OMCL: 1.10 )
OMCL' s 10-Year Price/Median PS Value Range
Min: 0.22   Max: 2.2
Current: 1.1

0.22
2.2
Price/Peter Lynch Fair Value 1.40
OMCL's Price/Peter Lynch Fair Value is ranked higher than
73% of the 484 Companies
in the Global Health Information Services industry.

( Industry Median: 1.59 vs. OMCL: 1.40 )
OMCL' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.69   Max: 23.38
Current: 1.4

0.69
23.38
Price/Graham Number 2.90
OMCL's Price/Graham Number is ranked higher than
59% of the 976 Companies
in the Global Health Information Services industry.

( Industry Median: 2.20 vs. OMCL: 2.90 )
OMCL' s 10-Year Price/Graham Number Range
Min: 1.29   Max: 18.72
Current: 2.9

1.29
18.72
Earnings Yield (Greenblatt) 5.00
OMCL's Earnings Yield (Greenblatt) is ranked higher than
67% of the 1463 Companies
in the Global Health Information Services industry.

( Industry Median: 5.60 vs. OMCL: 5.00 )
OMCL' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 15.9
Current: 5

0.2
15.9
Forward Rate of Return (Yacktman) 41.79
OMCL's Forward Rate of Return (Yacktman) is ranked higher than
96% of the 1296 Companies
in the Global Health Information Services industry.

( Industry Median: 5.77 vs. OMCL: 41.79 )
OMCL' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -6.2   Max: 43.2
Current: 41.79

-6.2
43.2

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, MDRX, AH » details
Traded in other countries:OC9.Germany
Omnicell, Inc., formerly Omnicell Technologies, Inc., is a Delaware corporation. The Company provides automation and business information solutions enabling healthcare systems to streamline medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Its automation, analytics and medication adherence solutions enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies and enhance patient safety, reduce medication errors, reduce operating costs, improve workflow and increase operational efficiency. Approximately 2,700 hospitals and 6,000 institutional and retail pharmacies utilize the company's products and services. The Company's business is organized into two operating business segments: Acute Care, which primarily includes products and services sold to hospital customers, offers analytics and reporting software for pharmacists and materials managers to manage inventory flow, tracking and optimization and Non-Acute Care, which primarily includes products and services sold to customers outside of the hospital setting and manufactures proprietary medication dispensing systems and related products for use by medication prescription providers: primarily institutional pharmacies servicing long-term care and correctional facilities. The Company is subject to taxes in the United States and other foreign jurisdictions.
» More Articles for OMCL

Headlines

Articles On GuruFocus.com
Ken Fisher's Top 5 New Portfolio Stocks Jul 27 2014 
comment on OMCL May 26 2013 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 1,250 Shares Feb 03 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 24 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 12 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 937 Shares Jan 05 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 3,351 Shares Dec 22 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 1,500 Shares Dec 03 2010 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 4,265 Shares Nov 30 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,372 Shares Oct 22 2010 


More From Other Websites
Omnicell Raises 2014 Guidance on SurgiChem Takeover Aug 26 2014
Omnicell Closes Acquisition of UK-Based Surgichem, Updates 2014 Guidance Aug 26 2014
OMNICELL, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 25 2014
Omnicell, Inc. Closes Acquisition of UK-Based Surgichem Limited and Updates 2014 Guidance Aug 25 2014
OMNICELL, INC Financials Aug 15 2014
Randall Lipps of Omnicell Elected into the Hall of Fame of Healthcare Supply Chain Leadership Aug 11 2014
OMNICELL, INC Files SEC form 10-Q, Quarterly Report Aug 07 2014
Omnicell Repeats as Top Overall Pharmacy Vendor in 2014 KLAS Pharmacy Equipment Rankings Aug 07 2014
Omnicell Shares Down Despite Q2 Earnings and Revenue Beat Aug 05 2014
OMNICELL, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 31 2014
Omnicell Announces Second Quarter Results Jul 31 2014
Q2 2014 Omnicell, Inc. Earnings Release - After Market Close Jul 31 2014
Atlantic Health Selects Omnicell Unity Enterprise Platform to Upgrade Existing Medication Automation... Jul 29 2014
Omnicell to Release Second Quarter 2014 Earnings Results on July 31 Jul 24 2014
Omnicell Down to Strong Sell Jun 17 2014
Omnicell Retains Balanced View May 29 2014
Omnicell management to meet with FBR Capital May 29 2014
Allina Health Selects Omnicell for Medication Automation Solutions May 28 2014
OMNICELL, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 21 2014
Omnicell initiated with an Overweight at Stephens May 20 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK